An AIDS Clinical Trials Group study reported an association between CYP2B6 516G>T SNP and neuropsychiatric symptoms within 1 week of efavirenz treatment, but not later, suggesting the development of tolerance to these adverse effects. The gene discussed is CYP2B6; the disease is AIDS.